Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society. Won HS, Ahn J, Kim Y, Kim JS, et al. Breast Cancer Res 2022;24:22.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Won HS, Ahn J, Kim Y, Kim JS, et al. Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society. Breast Cancer Res 2022;24:22.
PMID: 35307014